Health ❯ Healthcare

Liver Diseases

Metabolic Disorders Cirrhosis Metabolic Dysfunction Liver Transplantation Liver Cancer Chronic Hepatitis B Treatment Options Hepatology Bile Duct Disorders Non-Alcoholic Fatty Liver Disease Hepatitis D Inflammation and Fibrosis Cirrhosis Complications Diabetes Chronic Hepatitis Hepatorenal Syndrome NASH Fatty Liver Disease Hepatic Encephalopathy Metabolic Dysfunction-Associated Steatohepatitis

Altimmune Targets Second-Half 2026 Launch for Global Phase 3 MASH Trial

Fresh funding gives Altimmune runway through the planned 2029 readout.

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

First Therapeutic Pig-to-Human Liver Transplant Works for Weeks in Living Patient

HBsAg/HBV DNA Ratio Emerges as Strong Predictor of Progression in Immune-Tolerant Hepatitis B

Wegovy Wins FDA Nod for MASH as Novo Rolls Out $499 Cash Ozempic in U.S.

Validated AI Model for Cirrhosis Mortality Risk Rolled Out to Hospitals Worldwide

GPC3-Targeted PET Tracer Detects Early Liver Cancer With Unmatched Accuracy